DASATINIB
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+4
PRASCO LABS
Indication
Accelerated phase Philadelphia chromosome positive chronic myelocytic leukemia
Accelerated phase Philadelphia chromosome-positive chronic myelocytic leukemia is an advanced, transitional stage of a clonal myeloproliferative neoplasm affecting hematopoietic stem cells in the bone marrow and peripheral blood. Read more about Accelerated phase Philadelphia chromosome positive chronic myelocytic leukemia
56 drugs 40 manufacturers
Drugs that treat it
Common Accelerated phase Philadelphia chromosome positive chronic myelocytic leukemia therapies.
DASATINIB
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+4
BIOCON PHARMA I
DASATINIB
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+4
ZYDUS PHARMACEU
IMATINIB MESYLATE
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
ARMAS PHARMACEU
IMKELDI (imatinib mesylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
SHORLA PHARMA I
IMATINIB MESYLATE
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
QUALLENT PHARMA
IMATINIB MESYLATE
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
BLUEPOINT/ONCOP
NILOTINIB HCL
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA·+1
APOTEX CORP
DASATINIB
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+4
AUROBINDO PHARM
Filter & compare in the drug finder →Opens the drug finder with Accelerated phase Philadelphia chromosome positive chronic myelocytic leukemia preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAccelerated phase Philadelphia chromosome-positive chronic myelocytic leukemia is an advanced, transitional stage of a clonal myeloproliferative neoplasm affecting hematopoietic stem cells in the bone marrow and peripheral blood.
It is pathologically driven by the BCR::ABL1 fusion gene resulting from the reciprocal t(9;22)(q34;q11) translocation, known as the Philadelphia chromosome, which encodes a constitutively active tyrosine kinase.
The accelerated phase represents disease evolution beyond the indolent chronic phase toward acute blast transformation, characterized clinically by treatment-refractory leukocytosis or splenomegaly, elevated blast counts (typically 10% to 19%), persistent thrombocytosis or thrombocytopenia, prominent basophilia, and frequent cytogenetic clonal evolution.
- nih.gov
Accelerated phase Philadelphia chromosome-positive chronic myelocytic leukemia is an advanced, transitional stage of a clonal myeloproliferative neoplasm affecting hematopoietic stem cells in the bone marrow and peripheral blood It is pathologically driven by the BCR::ABL1 fusion gene resulting from the reciprocal t(9;22)(q34;q11) translocation, known as the Philadelphia chromosome, which encodes a constitutively active tyrosine kinase
- nih.gov
Accelerated phase Philadelphia chromosome-positive chronic myelocytic leukemia is an advanced, transitional stage of a clonal myeloproliferative neoplasm affecting hematopoietic stem cells in the bone marrow and peripheral blood The accelerated phase represents disease evolution beyond the indolent chronic phase toward acute blast transformation, characterized clinically by treatment-refractory leukocytosis or splenomegaly, elevated blast counts (typically 10% to 19%), persistent thrombocytosis ...
- nih.gov
It is pathologically driven by the BCR::ABL1 fusion gene resulting from the reciprocal t(9;22)(q34;q11) translocation, known as the Philadelphia chromosome, which encodes a constitutively active tyrosine kinase
Personalize your experience
Follow Accelerated phase Philadelphia chromosome positive chronic myelocytic leukemia and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.